Knowledge, Attitude and Practice about Allergic Rhinitis in Saudi Arabia, 2017

Abstract

Background: allergic rhinitis (AR) is considered a worldwide health disease therefore the lack of knowledge would result in poor adherence to management and preventive protocols and increasing the prevalence of AR. Objectives: evaluating the knowledge, attitude and practice(KAP) of Saudi adult subjects toward AR in Kingdom of Saudi Arabia (KSA). Methods: a cross sectional study conducted on 900 Saudi adult subjects admitted to primary health care centers. The subjects were interviewed and filled up a questionnaire including the respondent's demographics, questions related to knowledge, attitude and practice. Results: most of the respondents aged from31-45 years old, 59.7% were females and 49% were graduated from college.30% of participants had a family history of allergic rhinitis and 34% suffered from allergic rhinitis. Inadequate KAP was found among the participants with higher KAP scores related with higher educational degree. But there were no association between KAP level and gender or age. Conclusion: an inadequate knowledge was found among most of respondents thus resulting in poor attitude and practice pattern. Also, higher educational levels were associated with higher KAP scores.

Cardiovascular Risk Awareness and Calculated 10-Year Risk Among Female Employees at Taibah University 2019

“…Muhamad et al found limited knowledge and practice among the female patients in primary care facilities in Malaysia ( 32 ), while Fahs et al found good knowledge of CVD risk factors among the Lebanese population ( 23 ). Concerning stroke risk factors and warning symptoms, a study of Saudis by Alreshidi et al found that 63.8% of their participants had insufficient knowledge, attitudes, and practice ( 33 ). A second study by Alhazzani also showed a deficit in knowledge about strokes ( 34 ).…”

Impact of allergic rhinitis on the day-to-day lives of children: insights from an Australian cross-sectional study

“…The questionnaire explored 11 domains: (1) screening (International Study of Asthma and Allergies in Childhood (ISAAC) questionnaire), 15 (2) family medical history, (3) parent-perceived burden (as assessed by the validated single health status question; 16 and the validated Healthy Days questionnaire 17 and impact of AR on day-to-day living (adapted from Pediatric Allergies in America Survey)), 18 (4) beliefs about medicines (Beliefs about Medicines questionnaire), 19 (5) knowledge and beliefs about allergies (knowledge, attitude and practice questions in AR and asthma), 20–22 (6) AR classification (ARIA criteria), 1 23 (7) AR diagnosis, (8) AR triggers and testing, (9) AR symptoms (Contre les MAladies Chroniques pour un VIeillissement Actif (MACVIA)-ARIA validated visual analogue scales (VAS) 3 24 25 ), (10) symptom control (Control of Allergic Rhinitis and Asthma Test for Children) 26 and (11) AR management strategies. The length of the questionnaire was a key consideration; to minimise bias resulting from questionnaire fatigue, data collected about the survey respondents (parents/guardians) were minimal, with the majority of data relating to the specified child on whose behalf the questionnaire was being completed.…”

Safety Concerns of Nasal Corticosteroids Usage in Patients With Allergic Rhinitis

“…AR is a non-contagious inflammatory disease; it is caused by nasal hypersensitivity where immunoglobulin E is induced after a single allergen encounter, which results in an allergic reaction triggering inflammation 1 1 1 2 1 [6,10]. The inflammatory process caused by AR is similar to that found in other atopic inflammatory disorders, such as asthma, allergic conjunctivitis, and rhinosinusitis; a high asthma prevalence has been found in patients with severe cases of AR [11,12].…”

“…Allergic rhinitis (AR) is considered to be a common chronic respiratory disease in the general population, and it is one of the most common chronic diseases of childhood, representing a major public health concern in many countries worldwide [2][3][4][5]. In terms of prevalence, AR is estimated to affect from 10% to 35% of the population; however, these percentages could be inaccurate because some patients do not consider AR to be a disease [6,7]. In Saudi Arabia, a study conducted on 807 residents of the city of Al-Ahsa revealed that 76% of the study sample had been diagnosed with AR and had symptoms suggestive of AR [8].…”

“…Neglected AR imposes a significant emotional, social, and financial burden on patients and subsequently impairs their social life, work productivity, academic performance, and quality of sleep [22,23]. Previous literature has emphasized the lack of knowledge about INCSs and the necessity of patient education regarding safety concerns, the correct way to use these medications, and the assurance of their tolerance and satisfaction; this will eventually result in better patient compliance and health care outcomes [6,7,20,21]. No previous studies have been conducted in the region to address this issue despite the high-risk factors associated with AR and the availability of treatment.…”